About
Idevax is a medical device company active in skin drug delivery devices. We're based in Antwerp & Wijnegem, Belgium. The company’s flagship product is VAX-ID, a device allowing for accurate, reliable and user-independent intradermal vaccination, or vaccination in the skin with a high ease of use. VAX-ID is an award-winning, patented device. The device is CE marked since April 2025 and FDA approval is expected by Summer 2026. Key applications of the device include prophylactic and therapeutic vaccine delivery as well as immunotherapy.
THERAPEUTIC AREA
DermatologyImmunologyInfections and Infectious Diseases